ATAkiyoshi Tani

Akiyoshi Tani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akiyoshi Tani has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Hirotaka Tomiyasu

    Laboratory of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences the University of Tokyo Tokyo Japan

    2 shared publications
  • Atsushi Nakamura

    The TRVA Animal Medical Center, Tokyo Jonan Regional Veterinary Medicine Promotional Association, Tokyo 158-0081, Japan

    1 shared publication
  • Hiroki Sakuma

    Laboratory of Veterinary Internal Medicine, Veterinary Clinical Science Unit, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences The University of Tokyo Bunkyo Tokyo Japan

    1 shared publication
  • Hiroyuki Nakayama

    Laboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences the University of Tokyo Tokyo Japan

    1 shared publication
  • James K. Chambers

    Laboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences the University of Tokyo Tokyo Japan

    1 shared publication
  • Kazuyuki Uchida

    The University of Tokyo, Tokyo, Japan

    1 shared publication

Latest Publications

  • Open Access

    Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells

    by Hiroki Sakuma, Hirotaka Tomiyasu, Akiyoshi Tani, Yuko Goto‐Koshino, Makoto Bonkobara, Masaru Okuda

    The molecular abnormalities of canine histiocytic sarcoma (CHS) remain to be elucidated. We previously revealed that the sensitivities to dasatinib and trametinib were significantly various among CHS cell lines, indicating the differences in underlying molecular abnormalities. In the present study, we performed RNA sequencing analysis using 11 CHS cell lines to investigate molecular classifications based on the gene expression profiles (GEPs). The clustering analysis showed that CHS cell lines were divided into two distinct clusters. The comparisons of GEPs between the clusters extracted 675 differentially expressed genes (DEGs), and these DEGs were enriched with those related to the regulations of inflammatory responses. Among these DEGs, differences in the expressions of CCL3, CCL4, CCL7, CLEC7A, and TLR4 genes between the two groups were confirmed by RT‐qPCR. Since no significant difference in the activation status of Akt and ERK pathways was observed between the two groups, the NF‐κB pathway was focused on and its activation status was examined in the cell lines. As a result, cell lines belonging to one cluster showed nuclear translocation of the p65 protein together with increased release of CCL5 protein, which is a target molecule of the NF‐κB pathway, in a cell culture supernatant. These results suggested that the molecular pathology of CHS cells might be divided into two categories depending on the activation status of the NF‐κB pathway, and it is necessary to establish precision medicine for each molecular subtype of CHS.


  • Open Access

    The Prognostic Utility of Venous Blood Gas Analyses at Presentation in Cats with Cardiogenic Pulmonary Edema

    by Akiyoshi Tani, Ryohei Suzuki, Satoshi Matsukata, Atsushi Nakamura, Takaomi Nuruki

    Cats urgently visit emergency hospitals due to respiratory distress, and the chief cause is cardiogenic pulmonary edema (CPE). Although cats with CPE were frequently encountered in clinics, the prognostic factors were poorly reported. The objective of this retrospective study was to investigate the association of physical examination and venous blood gas parameters with the survival of cats with CPE in an emergency hospital. Thirty-six cats with CPE were ultimately included in the present study, and eight of them died within 12 h after their presentation to our hospital. Statistical analyses of clinical parameters between cats that died within 12 h and those that survived for 12 h were conducted using Mann–Whitney U test with Bonferroni correction. Cats that died within 12 h had significantly lower rectal temperatures and higher PvCO2 than those that did not die within 12 h. Moreover, hypotension and vasoconstrictor use were related to death within 12 h of presentation and higher PvCO2. These findings indicated the prognostic utility of body temperature and PvCO2, and the association between hypercapnia and the severity of CPE or hypotension. A large number of prospective studies should be performed to validate these results.

  • mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders

    by Miyuki Hirabayashi, James K. Chambers, Akiyoshi Tani, Hirotaka Tomiyasu, Tomoki Motegi, Kenji Rimpo, Hiroyuki Nakayama, Kazuyuki Uchida

    Canine histiocytic proliferative disorders include aggressive and fatal diseases, such as histiocytic sarcoma (HS) and histiocytosis (SyH). The molecular mechanisms underlying cell proliferation need to be elucidated for the development of effective treatments. In the present study, mRNA expression levels were comprehensively analysed in cell lines derived from localized HS, disseminated HS, SyH and Langerhans cell histiocytosis (LCH) in dogs. Based on the results obtained, the growth inhibitory effects of palbociclib, a CDK4/6 inhibitor, were verified with the cell lines in vitro and in xenograft mouse model. Hierarchical clustering and principal component analysis plots of mRNA expression profiles divided the cell lines into three groups: a localized HS group, disseminated HS/SyH group, and LCH. The results of an ingenuity pathway analysis suggested that the MAPK signalling pathway was activated in the localized HS and LCH cell lines, and the PI3K signalling pathway in the disseminated and localized HS cell lines. In all cell lines, the expression of the tumour suppressor genes TP53, CDKN2A and CDKN1A was down-regulated, whereas that of solid (Rb) was preserved. In vitro assessments revealed the growth inhibitory effects of palbociclib in all cell lines examined. In a xenograft mouse model using a cell line from disseminated HS, palbociclib exerted significant growth inhibitory effects. These results suggest the potential of palbociclib as a therapeutic drug candidate for the treatment of malignant histiocytic proliferative disorders of the dog.